Devex featured an op-ed from Management Sciences for Health President and CEO Marian Wentworth making the case for why a new dedicated R&D fund proposed by GHTC—called the Supporting Innovative Global Health Technologies (SIGHT) Fund—is needed at the US Agency for International Development to supercharge health research and bolster the agency’s ability to deliver accessible innovations to stock the global health toolbox of tomorrow.
Breakthroughs Blog: USAID
At a May congressional briefing, experts shared their perspectives on why a reinvigorated funding approach is needed to accelerate R&D of innovative global health technologies at the US Agency for International Development (USAID).
President signs spending bill that includes key boosts to global health research but no emergency funds for COVID-19
Months of tense congressional negotiations stretching nearly six months over schedule finally concluded with the signing of an omnibus spending package for fiscal year 2022. GHTC breaks down what that means for global health research.
As 2022 begins, GHTC is taking stock of the top global health R&D policy issues for the year ahead. Here are the top six topics GHTC will be tracking.